Google AI
The Times Australia

Times Media Advertising

ZEISS concludes fiscal year for the first time with revenue over 10 billion

- Exceptional growth with contributions from all four segments
- Expenditure in research and development amounted to 15% of revenue
- Around 43,000 employees globally, up 11% on the prior year
- Around 3.5 billion euros in investments in infrastructure planned for the next 5 years worldwide - around 3 billion of which to be invested in Germany
- Transformation into a data- and process-driven organization

OBERKOCHEN, GERMANY - Newsaktuell - 19 December 2023 - The ZEISS Group was able to continue its dynamic revenue growth with a growth rate at the very high level of the prior year.

In fiscal year 2022/23 (reporting date: 30 September 2023), revenue rose to over 10 billion euros for the first time in the company's history (prior year: 8.8 billion euros, up 15%). Earnings before interest and taxes (EBIT) were also up on the previous year at 1.7 billion euros (prior year:1.6 billion euros). All four segments of the ZEISS Group contributed to this growth despite the challenging market environment.

Caption
Segment development


"We can look back on another very successful fiscal year. To be able to continue this dynamic growth path in the future, we need to set the right course now. We are doing this by investing huge sums in our further development," said Dr. Karl Lamprecht, President and CEO of ZEISS. "Our success is based on our distinctive innovative strength. To ensure this continues, we have invested 15% of revenue in research and development, personnel development, and infrastructure – more than ever before."

Hashtag: #ZEISS

The issuer is solely responsible for the content of this announcement.

About ZEISS

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 10 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2023).

Find out more. Get in touch with The Times.

Invalid Input
Invalid Input
Invalid Input
Invalid Input

Times Magazine

Offshore vs Inshore Centre Console Boats: Which One Should You Buy?

Centre console boats have become one of the most popular choices among modern anglers. Their open ...

Why Australian Enterprises Are Rethinking Their Core Communication Technologies

The corporate landscape in Australia has undergone a permanent structural shift over the past few ...

Road safety risk: New data reveals almost 2 in 3 Australian drivers are letting car maintenance slide as cost of living pressures bite

Australians are putting off vehicle maintenance and new research released on the eve of National R...

Technology

Why Australian Enterprises Are Reth…

The corporate landscape in Australia has undergone a permanent structural shift over the past few ...

Local News

QLD Day

On Saturday 6 June, parkrun events across the state will be a sea of maroon, with communities  str...

Culture

Bacteria Found in Baby Wipes: Should Australi…

Parents rely on baby wipes every day. Whether changing nappies, cleaning little hands or wiping me...

Travel

Sri Lanka: An Island Adventure That Delivers …

For Australian travellers looking for a destination that combines tropical beaches, ancient histor...

The Times Features

Australia's Property Market Is Adjusting. So Are B…

Australia's housing market is entering a new phase. For much of the past decade, buyers became ac...

Bacteria Found in Baby Wipes: Should Australian Parents…

Parents rely on baby wipes every day. Whether changing nappies, cleaning little hands or wiping me...

Melbourne Real Estate Road Trip: North of the Yarra

Part Two of The Times' Melbourne property road trip series. Last week we explored Melbourne south...